• Citer

Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.

par Casado Arroyo, Ruben ;Polo-Tomás, M;Roncalés, Maria P;Scheiman, James;Lanas, Angel
Référence Heart, 98, 9, page (718-723)
Publication Publié, 2012-05

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Patients undergoing percutaneous coronary intervention require dual antiplatelet therapy. Proton-pump inhibitor (PPI) therapy is recommended for the prevention of upper GI complications. No study has determined the rate and type of GI bleeding events in such patients in routine clinical practice.